Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Alx Oncology Holdings Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- +2 vs. Q2 2022
- Shares held
- 36.4M
- +508.3K (+1.4%) vs. Q2 2022
- Total value
- $348.7M
- +$58.0M (+20.0%) vs. Q2 2022
- New holders
- 18
- 26 more added
- Sold out
- 16
- 32 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALXO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 93 | $217.9M |
| Q1 2026 | 69 | $189.0M |
| Q4 2025 | 57 | $33.0M |
| Q3 2025 | 61 | $50.8M |
| Q2 2025 | 61 | $12.1M |
| Q1 2025 | 85 | $21.7M |
| Q4 2024 | 87 | $68.5M |
| Q3 2024 | 92 | $82.7M |
| Q2 2024 | 112 | $293.4M |
| Q1 2024 | 106 | $510.5M |
| Q4 2023 | 93 | $681.5M |
| Q3 2023 | 76 | $159.8M |
| Q2 2023 | 75 | $257.5M |
| Q1 2023 | 86 | $161.4M |
| Q4 2022 | 87 | $410.6M |
| Q3 2022 | 99 | $348.7M |
| Q2 2022 | 97 | $290.7M |
| Q1 2022 | 96 | $621.9M |
| Q4 2021 | 108 | $780.0M |
| Q3 2021 | 115 | $2.55B |
| Q2 2021 | 105 | $1.82B |
| Q1 2021 | 94 | $2.47B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Alx Oncology Holdings Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −86,470−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −66,600−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −25,193−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −22,211−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −20,955−100.0% | Sold out |
| Connacht Asset Management LP | 0 | $0 | 0.00% | −20,953−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −15,510−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −13,251−100.0% | Sold out |
| Cim Investment Mangement Inc | 0 | $0 | 0.00% | −10,706−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −10,119−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −1,350−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −1,331−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −48−100.0% | Sold out |